Quantum BioPharma to Present at ArcStone-Kingswood Growth Summit

Quantum BioPharma, a biopharmaceutical company focused on developing innovative treatments for neurodegenerative and metabolic disorders, will participate in the 3rd Annual ArcStone-Kingswood Growth Summit in Toronto on September 16, 2026. The summit, held at the Sheraton Center Toronto Hotel, will bring together growth issuers and a curated group of investors, family offices, institutional investors, capital market professionals, and service providers for a full day of company presentations, networking, and one-on-one meetings.

Anthony Durkacz, Co-founder and Executive Co-chairman of the board of Quantum BioPharma, will present on the company's recent milestones and future growth strategy. The summit aims to provide a platform for companies to showcase their achievements and engage with potential investors.

Quantum BioPharma is dedicated to building a portfolio of innovative assets and biotech solutions for treating challenging neurodegenerative and metabolic disorders, as well as alcohol misuse disorders. The company has drug candidates in various stages of development. One of its key projects is Lucid-MS, a patented new chemical entity designed to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models.

Additionally, Quantum BioPharma has a subsidiary, Lucid Psycheceuticals Inc., which is focused on the research and development of Lucid-MS. The company also has a partnership with Unbuzzd Wellness Inc., formerly Celly Nutrition Corp., where it retains a 19.48% ownership stake as of June 30, 2026. The agreement includes royalty payments of 7% of sales from unbuzzd™ until payments total $250 million, after which the royalty drops to 3% in perpetuity.

The ArcStone-Kingswood Growth Summit, organized by ArcStone Securities and Investments Corp. and Kingswood US, is a financial services firm with offices in New York and Toronto. ArcStone specializes in providing bespoke solutions to mid-market companies, while Kingswood US focuses on investment banking, wealth management, and capital raising services in the United States.

The summit will feature keynote presentations, panel discussions, and conversations on industry developments. Interested investors can register for a free pass to attend the event. The company's participation in the summit is part of its ongoing efforts to engage with potential investors and showcase its progress and future plans.